Showing 11,741 - 11,760 results of 226,405 for search '(( a ((linear decrease) OR (a decrease)) ) OR ( a ((greater decrease) OR (larger decrease)) ))', query time: 1.24s Refine Results
  1. 11741

    Mean amplitude values during a complete 360° rotation for the longissimus muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  2. 11742

    Mean amplitude values during a complete 360° rotation for the multifidus muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  3. 11743

    Patient demographics. by Katrine Carlsen (5477300)

    Published 2024
    “…</p><p>Results</p><p>From 25 patients (median age 14.4 years) diagnosed with Crohn´s Disease (n = 16) or ulcerative colitis (n = 9), microbiota were analysed in 671 faecal samples collected across 15 treatment intervals.</p><p>A significant decrease over time in Shannon diversity, following the initial increase within four weeks of treatment, was found across patients. …”
  4. 11744

    Participant characteristics. by Katharyn L. Flickinger (4759323)

    Published 2025
    “…However, longer-acting dosing strategies are required to achieve greater levels of metabolic reduction. We explored whether a sublingual loading dose followed by subcutaneous infusion (SQI) of dexmedetomidine with and without surface cooling can decrease metabolic rate for 6 hours. …”
  5. 11745
  6. 11746

    Data_Sheet_1_IgA-Targeted Lactobacillus jensenii Modulated Gut Barrier and Microbiota in High-Fat Diet-Fed Mice.pdf by Jin Sun (117866)

    Published 2019
    “…This was related to significant up-regulation of mucin-2, PIgR mRNA expression, and colonic butyrate production (P < 0.05 vs. HFD). Unlike IgA21, FS1 caused a more pronounced gut dybiosis than did HFD, and, in particular, it induced a significant decrease in the Bacteroidales S24-7 group and an increase in Desulfovibrionaceae (P < 0.05 vs. …”
  7. 11747

    Role of EZH2 and G9a enzymes in histone methylation pattern and in miR-212 expression levels in NSCLC. by Mariarosaria Incoronato (197260)

    Published 2011
    “…These results suggest that in Calu-1 cells the upregulation of EZH2 and G9a enzymes contributes to increase histone methylation and thus to decrease miR-212 expression levels. …”
  8. 11748

    The <em>Drosophila melanogaster</em> CHD1 Chromatin Remodeling Factor Modulates Global Chromosome Structure and Counteracts HP1a and H3K9me2 by Lakshmi Bugga (393594)

    Published 2013
    “…Loss of CHD1 resulted in alterations of chromosome structure and an increase in the heterochromatin protein HP1a, while over-expression of CHD1 disrupted higher order chromatin structure and caused a decrease in levels of HP1a. …”
  9. 11749

    Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

    Published 2024
    “…</p><p>Results</p><p>From 25 patients (median age 14.4 years) diagnosed with Crohn´s Disease (n = 16) or ulcerative colitis (n = 9), microbiota were analysed in 671 faecal samples collected across 15 treatment intervals.</p><p>A significant decrease over time in Shannon diversity, following the initial increase within four weeks of treatment, was found across patients. …”
  10. 11750

    STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

    Published 2024
    “…</p><p>Results</p><p>From 25 patients (median age 14.4 years) diagnosed with Crohn´s Disease (n = 16) or ulcerative colitis (n = 9), microbiota were analysed in 671 faecal samples collected across 15 treatment intervals.</p><p>A significant decrease over time in Shannon diversity, following the initial increase within four weeks of treatment, was found across patients. …”
  11. 11751

    Plasma drug levels by group. by Katharyn L. Flickinger (4759323)

    Published 2025
    “…However, longer-acting dosing strategies are required to achieve greater levels of metabolic reduction. We explored whether a sublingual loading dose followed by subcutaneous infusion (SQI) of dexmedetomidine with and without surface cooling can decrease metabolic rate for 6 hours. …”
  12. 11752

    Change in physiologic data over time. by Katharyn L. Flickinger (4759323)

    Published 2025
    “…However, longer-acting dosing strategies are required to achieve greater levels of metabolic reduction. We explored whether a sublingual loading dose followed by subcutaneous infusion (SQI) of dexmedetomidine with and without surface cooling can decrease metabolic rate for 6 hours. …”
  13. 11753

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  14. 11754

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  15. 11755

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  16. 11756

    A homozygous missense variant in <i>VWA2</i>, encoding an interactor of the Fraser-complex, in a patient with vesicoureteral reflux by Amelie T. van der Ven (4782093)

    Published 2018
    “…We identified a homozygous missense mutation (c.1336C>T, p.Arg446Cys) in the gene <i>Von Willebrand factor A domain containing 2</i> (<i>VWA2</i>). …”
  17. 11757

    Palladium(II)–<i>N</i>‑Heterocyclic Carbene Complex-Based Electrocatalysts for Hydrogen Evolution Reaction by Geetha Basappa Markandeya (14497596)

    Published 2023
    “…The developed electrocatalysts exhibit excellent stability for up to 10 h with minimal decrease in efficiency, as indicated by the post-stability linear sweep voltammogram. …”
  18. 11758

    Palladium(II)–<i>N</i>‑Heterocyclic Carbene Complex-Based Electrocatalysts for Hydrogen Evolution Reaction by Geetha Basappa Markandeya (14497596)

    Published 2023
    “…The developed electrocatalysts exhibit excellent stability for up to 10 h with minimal decrease in efficiency, as indicated by the post-stability linear sweep voltammogram. …”
  19. 11759

    Palladium(II)–<i>N</i>‑Heterocyclic Carbene Complex-Based Electrocatalysts for Hydrogen Evolution Reaction by Geetha Basappa Markandeya (14497596)

    Published 2023
    “…The developed electrocatalysts exhibit excellent stability for up to 10 h with minimal decrease in efficiency, as indicated by the post-stability linear sweep voltammogram. …”
  20. 11760

    Palladium(II)–<i>N</i>‑Heterocyclic Carbene Complex-Based Electrocatalysts for Hydrogen Evolution Reaction by Geetha Basappa Markandeya (14497596)

    Published 2023
    “…The developed electrocatalysts exhibit excellent stability for up to 10 h with minimal decrease in efficiency, as indicated by the post-stability linear sweep voltammogram. …”